MedTrace Logo

Physiologically Guided VT Ablation

NCT04004624 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of VT ablation guided by functional evaluation of the substrate to specifically target the reentry-vulnerable zones in patients with infarct-related VT.

Conditions

  • Ventricular Tachycardia

Interventions

DEVICE

Ablation

Cardiac Ablation

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Center for Cardiovascular Reseach and Innovation

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-12
Primary Completion
2019-09-16
Completion
2020-01-01
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04004624 on ClinicalTrials.gov